Victoria Goodfellow

Victoria Goodfellow is a senior health financing expert with over two decades of experience across healthcare financing and investment banking.

Victoria has focused largely on expanding access to essential health commodities in sub-Saharan Africa, through roles spanning system-level financing, innovative finance and the procurement of medicines and diagnostics for infectious diseases. Her breadth of experience gives her a whole-system perspective on the barriers to access, the role of innovative financing tools and the importance of collaboration to maximise impact.

At MedAccess, Victoria is Head of Infectious Diseases. She works with partners to identify opportunities where innovative finance can overcome barriers to accessing health innovations. She plays a leading role in shaping and executing agreements that accelerate access to life-saving products. Her responsibilities span the full investment lifecycle – from originating opportunities and engaging global health stakeholders on market failures, to structuring and executing transactions that deliver measurable impact.

Before joining MedAccess, Victoria held senior roles across healthcare financing and access to medicines. She was Chief Strategy Officer at Maisha Meds, supporting the scale-up of malaria testing and treatment across pharmacies and clinics in Africa. As Managing Director at Lion’s Head Global Partners, she led the healthcare practice, advising major foundations and multilaterals on projects including vaccine financing, cold chain, malaria elimination, HIV testing and antibiotics R&D. She also worked as Senior Technical Advisor at CHAI, leading advisory work on health insurance reform in Ethiopia, and as an economist in the UK government on healthcare financing in the acute care sector. Earlier in her career, she spent a decade in emerging market equities at UBS, Citigroup and Barclays.

Victoria holds a Master’s in International Health Policy (Health Economics) from the London School of Economics and a Bachelor of Economic Science from the University of Manchester.